Agnes Weixuan Yu
YOU?
Author Swipe
View article: Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer
Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer Open
Despite the OlympiA trial demonstrating that early-stage, high-risk, HER2- germline BRCA1 and BRCA2 mutation (gBRCAm) positive breast cancer patients can benefit from PARPi in the adjuvant setting, the gBRCA testing rate in early-stage HR+…
View article: PD55-08 WIDESPREAD USE OF MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT RESULTS IN EARLIER IDENTIFICATION AND TREATMENT OF CLINICALLY SIGNIFICANT PROSTATE CANCER
PD55-08 WIDESPREAD USE OF MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT RESULTS IN EARLIER IDENTIFICATION AND TREATMENT OF CLINICALLY SIGNIFICANT PROSTATE CANCER Open
You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance III (PD55)1 Apr 2019PD55-08 WIDESPREAD USE OF MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT RESULTS IN EARLIER IDENTIFICATION AND TREATMENT OF CLINICAL…